The mRNA technology market, valued at USD 35.67 billion in 2023, is projected to nearly double and reach USD 76.45 billion by 2032, growing at a CAGR of 8.88% during the forecast period of 2024–2032. This rapid growth reflects the transformative impact of mRNA technology on modern medicine, with applications ranging from infectious disease prevention to cancer immunotherapy, genetic...